Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral alitretinoin for palmo-plantar pustulosis
NL-OMON36734Phase 2Active, not recruiting
- Sponsor
- Basilea Pharmaceutica
- Start
- Sep 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alitretinoin in Palmoplantar Pustular Psoriasis (PPPP), sponsored by Basilea Pharmaceutica. Started Sep 2011; status: active, not recruiting.
02
Drugs
alitretinoin
03
Conditions
Palmoplantar Pustular Psoriasis (PPPP)
Beyond the preview
Go deeper on NL-OMON36734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36734.